Skip to Content

WATSON 668 (Enalapril 2.5 mg)

Pill imprint WATSON 668 has been identified as Enalapril maleate 2.5 mg.

Enalapril is used in the treatment of high blood pressure; heart failure; diabetic kidney disease; hypertensive emergency; alport syndrome (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Enalapril 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Enalapril maleate 2.5 mg WATSON 668
Enalapril maleate 2.5 mg WATSON 668
Discount Card Promo
Enalapril maleate
Imprint:
WATSON 668
Strength:
2.5 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0668
Inactive Ingredients:
lactose anhydrous
crospovidone
magnesium stearate
microcrystalline cellulose
potassium bicarbonate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide